JAMA Oncol:儿童癌症幸存者的听力障碍(HI)与神经认知能力的关系

2020-08-13 ioncology 肿瘤瞭望

听力障碍是一种严重的医学疾病,而听力障碍似乎与神经认知缺陷风险的增加有关。一项横断面研究通过治疗暴露分层进一步分析了儿童癌症长期幸存者队列中的听力敏感性和特定任务神经认知功能的关系。

听力障碍是一种严重的医学疾病,尤其是在未被发现或未治疗的情况下,而听力障碍似乎与神经认知缺陷风险的增加有关。近日,美国学者发表在JAMA Oncology杂志的一项横断面研究通过治疗暴露分层进一步分析了儿童癌症长期幸存者队列中的听力敏感性和特定任务神经认知功能的关系。

在美国,癌症儿童的长期生存已经超过了85%。尽管癌症治疗和支持性护理取得了进展,但儿童癌症幸存者仍面临疾病和治疗相关的慢性疾病的风险,如听力障碍(HI)和神经认知障碍。在幸存者中,接受中枢神经系统(CNS)放射治疗(RT)的恶性肿瘤患者发生神经认知功能障碍的风险最高,治疗引起的HI通常与基于铂化疗或对耳蜗进行放射治疗有关,并且通常是双侧的、永久性的、进行性的。

健康儿童中HI和神经认知障碍之间的关系已经在既往文献中报道过,但是最近才在儿童癌症幸存者中进行研究。Gurney等人观察到,神经母细胞瘤的儿童幸存者在阅读、数学和/或注意力方面有困难可能性是父母报告的HI的两倍,需要更多的特殊教育服务;与听力正常的人相比,他们的生活质量更差。与这些不良结果相关的特定的不良认知区域没有被确定。

在一项对5937名非中枢神经系统成年幸存者的回顾性研究中,研究显示HI与任务效率、组织、记忆力和情绪调节能力降低相关。然而,神经认知功能和HI是自我报告的,而不是临床评估的。既往关于HI对接受铂类化疗和颅RT治疗的儿童中枢神经系统肿瘤幸存者的影响的研究表明,HI与低水平的神经认知功能之间存在独立的关联。未接受脑放射治疗的儿童癌症幸存者的HI与神经认知功能的关系尚未被报道。

为客观评估儿童癌症幸存者中HI的患病率、严重程度和风险,探讨HI与神经认知功能的关系,研究者选取了2007年4月25日至2017年6月30日参与 St. Jude终生队列研究(SJLIFE)中符合条件的幸存者的数据,并进行了研究。该横断面研究旨在量化儿童癌症幸存者的长期健康结果。参与者包括在 St. Jude儿童研究医院(孟菲斯,田纳西州)接受治疗的儿童癌症患者,他们在最初诊断后存活了5年或更长时间,并且有资格接受听力学和神经认知测试。使用Chang耳毒性分级量表对听力结果进行编码。数据分析时间为2019年3月22日至2020年3月5日。

儿童癌症幸存者被根据听力灵敏度(正常听力[Chang 0级],轻度HI [Chang 1a,1b和2a级]或重度HI [Chang 2b级])和治疗暴露量(纯铂暴露组[顺铂和/或卡铂化疗治疗]、耳蜗RT暴露组[耳蜗放疗加或不加铂化疗治疗]、无暴露组[无铂化疗或耳蜗放疗])进行分组。多变量对数二项模型被调整为诊断时的年龄、自诊断以来的时间、性别和相关的治疗暴露。

该研究共分析1520例儿童癌症幸存者的相关数据,其中为814名男性(53.6%),中位年龄(四分位间距[IQR])为29.4(7.4-64.7)岁,中位(IQR)确诊时间是20.4(6.1-53.8)年。研究结果显示,纯铂暴露组幸存者发生中重度HI的风险较高(107 [34.9%]),RR为1.68 [95% CI, 1.20~2.37],耳蜗RT暴露组为181 [38.3%];暴露组的RR值为2.69 [95% CI 2.02~3.57],未暴露组RR值为65[8.8%]。

重度HI与语言推理能力缺失相关(未暴露组RR, 1.11 [95% CI, 0.50~2.43];纯铂暴露组RR, 1.93 [95% CI, 1.21~3.08];耳蜗RT暴露组RR, 2.00 [95% CI, 1.46~2.75]),语言流畅性(未暴露组RR, 1.86 [95% CI, 1.19~2.91]);纯铂暴露组RR, 1.83 [95% CI, 1.24~2.71];耳蜗RT暴露组RR, 1.45 [95% CI, 1.09~1.94],视运动速度(未暴露组RR, 1.87 [95% CI, 1.07~3.25];纯铂暴露组RR, 3.10 [95% CI, 1.92~4.99];耳蜗RT暴露组RR, 1.40 [95% CI, 1.11~1.78]),数学能力(未暴露组RR, 1.90 [95% CI, 1.18~3.04];纯铂暴露组RR, 1.63 [95% CI, 1.05-2.53]);与听力正常或轻度HI患者相比,耳蜗RT暴露组RR为1.58 [95% CI, 1.15-2.18]。

这项研究的结果表明,在儿童癌症幸存者中严重的HI与神经认知缺陷相关,而不依赖于所接受的神经毒性治疗。HI的早期筛查和干预可以促进神经认知功能的发展和维持,并识别有损伤风险的个体。

研究者还提出,对HI的早期筛查和干预,包括坚持使用助听器和耳蜗植入、神经心理咨询和教育设施可能促进神经认知功能的发展和维护,并可能识别出哪些人有未来损伤的风险。因此,有必要进一步对儿童癌症幸存者使用助听器与神经认知结果之间的关系进行前瞻性研究。

原始出处:

Johnnie K Bass, Wei Liu, Pia Banerjee, et al.Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer.JAMA Oncol. 2020 Jul 30. doi: 10.1001/jamaoncol.2020.2822.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1952364, encodeId=dac91952364da, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Wed Dec 02 00:58:51 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865885, encodeId=e41b186588569, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sun Aug 16 11:58:51 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306547, encodeId=567b130654e79, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438801, encodeId=68b81438801dc, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511136, encodeId=f2b615111369d, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534961, encodeId=d5d4153496128, content=<a href='/topic/show?id=a29d392e500' target=_blank style='color:#2F92EE;'>#听力障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39275, encryptionId=a29d392e500, topicName=听力障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a9b12571322, createdName=lg.zhao, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603523, encodeId=8a54160352339, content=<a href='/topic/show?id=ef43e455710' target=_blank style='color:#2F92EE;'>#神经认知#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74557, encryptionId=ef43e455710, topicName=神经认知)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6519038657, createdName=szhvet, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036221, encodeId=60e3103622120, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038087, encodeId=faa7103808e20, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1952364, encodeId=dac91952364da, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Wed Dec 02 00:58:51 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865885, encodeId=e41b186588569, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sun Aug 16 11:58:51 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306547, encodeId=567b130654e79, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438801, encodeId=68b81438801dc, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511136, encodeId=f2b615111369d, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534961, encodeId=d5d4153496128, content=<a href='/topic/show?id=a29d392e500' target=_blank style='color:#2F92EE;'>#听力障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39275, encryptionId=a29d392e500, topicName=听力障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a9b12571322, createdName=lg.zhao, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603523, encodeId=8a54160352339, content=<a href='/topic/show?id=ef43e455710' target=_blank style='color:#2F92EE;'>#神经认知#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74557, encryptionId=ef43e455710, topicName=神经认知)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6519038657, createdName=szhvet, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036221, encodeId=60e3103622120, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038087, encodeId=faa7103808e20, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-16 minlingfeng
  3. [GetPortalCommentsPageByObjectIdResponse(id=1952364, encodeId=dac91952364da, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Wed Dec 02 00:58:51 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865885, encodeId=e41b186588569, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sun Aug 16 11:58:51 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306547, encodeId=567b130654e79, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438801, encodeId=68b81438801dc, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511136, encodeId=f2b615111369d, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534961, encodeId=d5d4153496128, content=<a href='/topic/show?id=a29d392e500' target=_blank style='color:#2F92EE;'>#听力障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39275, encryptionId=a29d392e500, topicName=听力障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a9b12571322, createdName=lg.zhao, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603523, encodeId=8a54160352339, content=<a href='/topic/show?id=ef43e455710' target=_blank style='color:#2F92EE;'>#神经认知#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74557, encryptionId=ef43e455710, topicName=神经认知)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6519038657, createdName=szhvet, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036221, encodeId=60e3103622120, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038087, encodeId=faa7103808e20, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-15 ysjykql
  4. [GetPortalCommentsPageByObjectIdResponse(id=1952364, encodeId=dac91952364da, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Wed Dec 02 00:58:51 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865885, encodeId=e41b186588569, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sun Aug 16 11:58:51 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306547, encodeId=567b130654e79, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438801, encodeId=68b81438801dc, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511136, encodeId=f2b615111369d, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534961, encodeId=d5d4153496128, content=<a href='/topic/show?id=a29d392e500' target=_blank style='color:#2F92EE;'>#听力障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39275, encryptionId=a29d392e500, topicName=听力障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a9b12571322, createdName=lg.zhao, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603523, encodeId=8a54160352339, content=<a href='/topic/show?id=ef43e455710' target=_blank style='color:#2F92EE;'>#神经认知#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74557, encryptionId=ef43e455710, topicName=神经认知)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6519038657, createdName=szhvet, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036221, encodeId=60e3103622120, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038087, encodeId=faa7103808e20, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1952364, encodeId=dac91952364da, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Wed Dec 02 00:58:51 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865885, encodeId=e41b186588569, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sun Aug 16 11:58:51 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306547, encodeId=567b130654e79, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438801, encodeId=68b81438801dc, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511136, encodeId=f2b615111369d, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534961, encodeId=d5d4153496128, content=<a href='/topic/show?id=a29d392e500' target=_blank style='color:#2F92EE;'>#听力障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39275, encryptionId=a29d392e500, topicName=听力障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a9b12571322, createdName=lg.zhao, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603523, encodeId=8a54160352339, content=<a href='/topic/show?id=ef43e455710' target=_blank style='color:#2F92EE;'>#神经认知#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74557, encryptionId=ef43e455710, topicName=神经认知)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6519038657, createdName=szhvet, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036221, encodeId=60e3103622120, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038087, encodeId=faa7103808e20, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1952364, encodeId=dac91952364da, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Wed Dec 02 00:58:51 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865885, encodeId=e41b186588569, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sun Aug 16 11:58:51 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306547, encodeId=567b130654e79, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438801, encodeId=68b81438801dc, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511136, encodeId=f2b615111369d, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534961, encodeId=d5d4153496128, content=<a href='/topic/show?id=a29d392e500' target=_blank style='color:#2F92EE;'>#听力障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39275, encryptionId=a29d392e500, topicName=听力障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a9b12571322, createdName=lg.zhao, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603523, encodeId=8a54160352339, content=<a href='/topic/show?id=ef43e455710' target=_blank style='color:#2F92EE;'>#神经认知#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74557, encryptionId=ef43e455710, topicName=神经认知)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6519038657, createdName=szhvet, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036221, encodeId=60e3103622120, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038087, encodeId=faa7103808e20, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1952364, encodeId=dac91952364da, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Wed Dec 02 00:58:51 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865885, encodeId=e41b186588569, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sun Aug 16 11:58:51 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306547, encodeId=567b130654e79, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438801, encodeId=68b81438801dc, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511136, encodeId=f2b615111369d, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534961, encodeId=d5d4153496128, content=<a href='/topic/show?id=a29d392e500' target=_blank style='color:#2F92EE;'>#听力障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39275, encryptionId=a29d392e500, topicName=听力障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a9b12571322, createdName=lg.zhao, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603523, encodeId=8a54160352339, content=<a href='/topic/show?id=ef43e455710' target=_blank style='color:#2F92EE;'>#神经认知#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74557, encryptionId=ef43e455710, topicName=神经认知)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6519038657, createdName=szhvet, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036221, encodeId=60e3103622120, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038087, encodeId=faa7103808e20, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1952364, encodeId=dac91952364da, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Wed Dec 02 00:58:51 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865885, encodeId=e41b186588569, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sun Aug 16 11:58:51 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306547, encodeId=567b130654e79, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438801, encodeId=68b81438801dc, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511136, encodeId=f2b615111369d, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534961, encodeId=d5d4153496128, content=<a href='/topic/show?id=a29d392e500' target=_blank style='color:#2F92EE;'>#听力障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39275, encryptionId=a29d392e500, topicName=听力障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a9b12571322, createdName=lg.zhao, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603523, encodeId=8a54160352339, content=<a href='/topic/show?id=ef43e455710' target=_blank style='color:#2F92EE;'>#神经认知#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74557, encryptionId=ef43e455710, topicName=神经认知)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6519038657, createdName=szhvet, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036221, encodeId=60e3103622120, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038087, encodeId=faa7103808e20, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-13 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1952364, encodeId=dac91952364da, content=<a href='/topic/show?id=806a28364b6' target=_blank style='color:#2F92EE;'>#儿童癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28364, encryptionId=806a28364b6, topicName=儿童癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Wed Dec 02 00:58:51 CST 2020, time=2020-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1865885, encodeId=e41b186588569, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13350, encryptionId=16ce133504e, topicName=Oncol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b63894, createdName=minlingfeng, createdTime=Sun Aug 16 11:58:51 CST 2020, time=2020-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306547, encodeId=567b130654e79, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438801, encodeId=68b81438801dc, content=<a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71349, encryptionId=5e61e13494d, topicName=癌症幸存者)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511136, encodeId=f2b615111369d, content=<a href='/topic/show?id=e1372836021' target=_blank style='color:#2F92EE;'>#儿童癌症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28360, encryptionId=e1372836021, topicName=儿童癌症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a3910291816, createdName=guozhenyu, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534961, encodeId=d5d4153496128, content=<a href='/topic/show?id=a29d392e500' target=_blank style='color:#2F92EE;'>#听力障碍#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39275, encryptionId=a29d392e500, topicName=听力障碍)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a9b12571322, createdName=lg.zhao, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603523, encodeId=8a54160352339, content=<a href='/topic/show?id=ef43e455710' target=_blank style='color:#2F92EE;'>#神经认知#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74557, encryptionId=ef43e455710, topicName=神经认知)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e6519038657, createdName=szhvet, createdTime=Sat Aug 15 02:58:51 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036221, encodeId=60e3103622120, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1038087, encodeId=faa7103808e20, content=谢谢梅斯分享这么多精彩信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=anti-cancer, createdTime=Thu Aug 13 14:58:51 CST 2020, time=2020-08-13, status=1, ipAttribution=)]
    2020-08-13 anti-cancer

    谢谢梅斯分享这么多精彩信息

    0

相关资讯

Lancet:儿童癌症生存者面临更为严峻的健康问题

儿童癌症患者的10年生存已超过80%,数据显示生存者终生都处于治疗相关并发症发生风险增高的状态,这一主题一直被忽略,但却非常有必要得到重视。美国Bhakta教授近期发表在LANCET上的文章对这一问题进行了研究,结果公布后引起关于儿童癌症生存者健康问题的热议。

JCO:儿童癌症幸存者应如何规避未来的恶性肿瘤?

既往是研究发现儿童癌症幸存者(Childhood cancer survivors,CCS)随后的恶性肿瘤(subsequent malignant neoplasms,SMN)风险在增加。近来,研究人员在一个表征良好的5年CCS队列研究中评估了SMN的长期风险,研究特别关注了个体化疗药物和实体瘤风险。研究人员对荷兰儿童癌症肿瘤组儿童癌症队列后的长期影响进行了研究,共包括1963年-2001年在荷

《柳叶刀》权威报告:儿童癌症近一半被漏诊、越来越多年轻人患癌症

要点:  1)据估计,2015年全球有17.2万(43%)的儿童癌症病例未被诊断出来                   2)世界上大多数地区最常见的儿童癌症是急性淋巴细胞白血病3)美国20年的数据显示,在年轻成人中,癌症发病率正在增加以往对全球儿童癌症总发病率的估计主要是基

Lancet Oncology:2001 -2010年间国际儿童癌症发病率

研究者近日统计了过去的十年国际儿童癌症发病率

Hepatology:儿童癌症幸存者血清ALT升高:圣裘德终生队列研究报告

3级或4级肝损伤在CCS中并不常见。在这一组,生活方式的改变可能影响轻度肝损伤的状况。

每3分钟就有1个孩子死于癌症!儿童癌症全新治疗进展盘点

在刚结束的2019年美国临床肿瘤学会年会(2019 ASCO)上,纪念斯隆凯特琳儿童癌症中心(MSK Kids)的科学家介绍了儿童癌症治疗的最新进展,包括关于靶向治疗的重磅消息和一种充满前景的罕见脑肿瘤药物输送技术。